Evidence map›Paper›PMID 40198462›Full record

SynthesisGeroScience2025

Treatment delay significantly increases mortality in colorectal cancer: a meta-analysis.

Zoltan Ungvari, Mónika Fekete, János Tibor Fekete, Andrea Lehoczki, Annamaria Buda, Gyöngyi Munkácsy, Péter Varga, Anna Ungvari, Balázs Győrffy

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zoltan Ungvari *Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mónika Fekete *Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Budapest, Hungary.
János Tibor Fekete *Dept. Of Bioinformatics, Semmelweis University, 1094, Budapest, Hungary.
Andrea Lehoczki *Institute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Budapest, Hungary.
Annamaria BudaInstitute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Budapest, Hungary.
Gyöngyi MunkácsyDept. Of Bioinformatics, Semmelweis University, 1094, Budapest, Hungary.
Péter VargaInstitute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Budapest, Hungary.
Anna UngvariInstitute of Preventive Medicine and Public Health, Semmelweis University, Semmelweis University, Budapest, Hungary. Ungann2004@gmail.com.ORCID 0009-0001-5053-2828
Balázs GyőrffyJozsef Fodor Center for Prevention and Healthy Aging, Semmelweis University, Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delaying the initiation of cancer treatment increases the risk of mortality, particularly in colorectal cancer (CRC), which is among the most common and deadliest malignancies. This study aims to explore the impact of treatment delays on mortality in CRC. A systematic literature search was conducted in PubMed, Web of Science, and Scopus for studies published between 2000 and 2025. Meta-analyses were performed using random-effects models with inverse variance method to calculate hazard ratios (HRs) for both overall and cancer-specific survival at 4-, 8-, and 12-week treatment delay intervals, with heterogeneity assessed through I

Indexed as

Colorectal NeoplasmsTime-to-TreatmentHumansTime FactorsTreatment DelayCancer survivalCancer treatment accessColorectal cancerDiagnostic delaysFrailtyGeriatric oncologyHealthcare disparitiesHealthcare inefficienciesMultimorbidityOncology care pathwaysPatient navigationReferral pathwaysTelemedicineTime-to-treatment benchmarksTreatment delay

Identifiers

PMID40198462
PMCPMC12181597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.